Authors:
Baraldi, PG
Cacciari, B
Romagnoli, R
Klotz, KN
Spalluto, G
Varani, K
Gessi, S
Merighi, S
Borea, PA
Citation: Pg. Baraldi et al., Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor ligands: A starting point for searching A(2B) adenosine receptor antagonists, DRUG DEV R, 53(2-3), 2001, pp. 225-235
Authors:
Baraldi, PG
Cacciari, B
Romagnoli, R
Spalluto, G
Varani, K
Cessi, S
Merighi, S
Borea, PA
Citation: Pg. Baraldi et al., Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new pharmacological tool for the characterization of the human A(3) adenosine receptor, DRUG DEV R, 52(1-2), 2001, pp. 406-415
Authors:
Baraldi, PG
Cacciari, B
Moro, S
Romagnoli, R
Ji, XD
Jacobson, KA
Gessi, S
Borea, PA
Spalluto, G
Citation: Pg. Baraldi et al., Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalizedpyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: Irreversible antagonists at the human A(3) adenosine receptor and molecular modeling studies, J MED CHEM, 44(17), 2001, pp. 2735-2742
Authors:
Baraldi, PG
Cacciari, B
Romagnoli, R
Varani, K
Merighi, S
Gessi, S
Borea, PA
Leung, E
Hickey, SL
Spalluto, G
Citation: Pg. Baraldi et al., Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: thefirst high affinity radioligand antagonist for the human A(3) adenosine receptors, BIOORG MED, 10(3), 2000, pp. 209-211
Authors:
Baraldi, PG
Cacciari, B
Romagnoli, R
Varani, K
Merighi, S
Gessi, S
Borea, PA
Leung, E
Hickey, SL
Spalluto, G
Citation: Pg. Baraldi et al., Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: thefirst high affinity radioligand antagonist for the human A(3) adenosine receptors (vol 10, pg 209, 2000), BIOORG MED, 10(12), 2000, pp. 1403-1403
Authors:
Varani, K
Merighi, S
Gessi, S
Klotz, KN
Leung, E
Baraldi, PG
Cacciari, B
Romagnoli, R
Spalluto, G
Borea, PA
Citation: K. Varani et al., [H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors, MOLEC PHARM, 57(5), 2000, pp. 968-975
Authors:
Baraldi, PG
Cacciari, B
Romagnoli, R
Spalluto, G
Moro, S
Klotz, KN
Leung, E
Varani, K
Gessi, S
Merighi, S
Borea, PA
Citation: Pg. Baraldi et al., Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: Influence of thechain at the N-8 pyrazole nitrogen, J MED CHEM, 43(25), 2000, pp. 4768-4780
Authors:
Todde, S
Moresco, RM
Simonelli, F
Baraldi, PG
Cacciari, B
Spalluto, G
Varani, K
Monopoli, A
Matarrese, M
Carpinelli, A
Magni, F
Kienle, MG
Fazio, F
Citation: S. Todde et al., Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography, J MED CHEM, 43(23), 2000, pp. 4359-4362
Authors:
Baraldi, PG
Cacciari, B
Romagnoli, R
Spalluto, G
Boyce, CW
Boger, DL
Citation: Pg. Baraldi et al., Resolution of a CPzI precursor, synthesis and biological evaluation of (+)and (-)-N-Boc-CPzI: A further validation of the relationship between chemical solvolytic stability and cytotoxicity, BIOORG MED, 9(21), 1999, pp. 3087-3092
Authors:
Bianchi, N
Spalluto, G
Cacciari, B
Romagnoli, R
Feriotto, G
Mischiati, C
Rutigliano, C
Borsetti, E
Baraldi, PG
Gambari, R
Citation: N. Bianchi et al., Selective binding to human genomic sequences of two synthetic analogues structurally related to U-71184 and adozelesin, DRUG DEV R, 46(2), 1999, pp. 96-106
Authors:
Baraldi, PG
Borea, PA
Bergonzoni, M
Cacciari, B
Ongini, E
Recanatini, M
Spalluto, G
Citation: Pg. Baraldi et al., Comparative molecular field analysis (CoMFA) of a series of selective adenosine receptor A(2A) antagonists, DRUG DEV R, 46(2), 1999, pp. 126-133
Authors:
Baraldi, PG
Cacciari, B
Romagnoli, R
Spalluto, G
Citation: Pg. Baraldi et al., An efficient procedure for the synthesis of 5H-6-substituted-pyrazolo[1,5-d]-1,2,4-triazine-4,7-diones, SYNTHESIS-S, (3), 1999, pp. 453-458
Authors:
Baraldi, PG
Balboni, G
Cacciari, B
Guiotto, A
Manfredini, S
Romagnoli, R
Spalluto, G
Thurston, DE
Howard, PW
Bianchi, N
Rutigliano, C
Mischiati, C
Gambari, R
Citation: Pg. Baraldi et al., Synthesis, in vitro antiproliferative activity, and DNA-binding propertiesof hybrid molecules containing pyrrolo[2,1-c][1,4]benzodiazepine and minor-groove-binding oligopyrrole carriers, J MED CHEM, 42(25), 1999, pp. 5131-5141
Authors:
Baraldi, PG
Cacciari, B
Romagnoli, R
Spalluto, G
Klotz, KN
Leung, E
Varani, K
Gessi, S
Merighi, S
Borea, PA
Citation: Pg. Baraldi et al., Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]-pyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists, J MED CHEM, 42(22), 1999, pp. 4473-4478
Authors:
Thurston, DE
Bose, DS
Howard, PW
Jenkins, TC
Leoni, A
Baraldi, PG
Guiotto, A
Cacciari, B
Kelland, LR
Foloppe, MP
Rault, S
Citation: De. Thurston et al., Effect of A-ring modifications on the DNA-binding behavior and cytotoxicity of pyrrolo[2,1-c] [1,4]benzodiazepines, J MED CHEM, 42(11), 1999, pp. 1951-1964
Authors:
Baraldi, PG
Cacciari, B
Romagnoli, R
Spalluto, G
Citation: Pg. Baraldi et al., 1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors, ARZNEI-FOR, 49(12), 1999, pp. 997-1000
Authors:
Baraldi, PG
Cacciari, B
Guiotto, A
Romagnoli, R
Spalluto, G
Citation: Pg. Baraldi et al., Heterocyclic analogs of pyrrolo [2,1-c] [1,4] benzodiazepines. Synthesis and structural requirements for their biological activity, RRD ORG CHE, 2, 1998, pp. 567-591